Morgan Stanley’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $329M | Sell |
|
|||||
|
2023
Q2 | $309M | Buy |
|
|||||
|
2023
Q1 | $231M | Buy |
|
|||||
|
2022
Q4 | $171M | Sell |
|
|||||
|
2022
Q3 | $105M | Buy |
|
|||||
|
2022
Q2 | $109M | Buy |
|
|||||
|
2022
Q1 | $133M | Sell |
|
|||||
|
2021
Q4 | $152M | Buy |
|
|||||
|
2021
Q3 | $138M | Buy |
|
|||||
|
2021
Q2 | $70.6M | Buy |
|
|||||
|
2021
Q1 | $62.4M | Sell |
|
|||||
|
2020
Q4 | $56M | Sell |
|
|||||
|
2020
Q3 | $67.5M | Buy |
|
|||||
|
2020
Q2 | $21.3M | Buy |
|
|||||
|
2020
Q1 | $10.3M | Buy |
|
|||||
|
2019
Q4 | $11.7M | Buy |
|
|||||
|
2019
Q3 | $7.87M | Buy |
|
|||||
|
2019
Q2 | $6.28M | Sell |
|
|||||
|
2019
Q1 | $12.1M | Sell |
|
|||||
|
2018
Q4 | $12.1M | Sell |
|
|||||
|
2018
Q3 | $23.1M | Buy |
|
|||||
|
2018
Q2 | $7.58M | Sell |
|
|||||
|
2018
Q1 | $8.47M | Buy |
|
|||||
|
2017
Q4 | $7.23M | Sell |
|
|||||
|
2017
Q3 | $9.89M | Sell |
|
|||||
|
2017
Q2 | $16.1M | Sell |
|
|||||
|
2017
Q1 | $21M | Buy |
|
|||||
|
2016
Q4 | $14.4M | Sell |
|
|||||
|
2016
Q3 | $25.5M | Buy |
|
|||||
|
2016
Q2 | $11.6M | Buy |
|
|||||
|
2016
Q1 | $1.98M | Sell |
|
|||||
|
2015
Q4 | $11.9M | Buy |
|
|||||
|
2015
Q3 | $7.18M | Sell |
|
|||||
|
2015
Q2 | $19.1M | Buy |
|
|||||
|
2015
Q1 | $9.31M | Buy |
|
|||||
|
2014
Q4 | $1.78M | Sell |
|
|||||
|
2014
Q3 | $4.19M | Sell |
|
|||||
|
2014
Q2 | $7.19M | Buy |
|
|||||
|
2014
Q1 | $6.58M | Sell |
|
|||||
|
2013
Q4 | $4.24M | Buy |
|
|||||
|
2013
Q3 | $96K | Buy |
|